The world's largest pharmaceutical market access conference
As the senior civil servant executive of the PMPRB, Michelle is responsible for the corporate leadership of the agency, including its strategic direction, voluntary compliance and pricing guidelines, and the management of human and financial resources. Michelle has…more ›
Meindert was trained as a pharmacist in the Netherlands and joined NICE in 2004 as a health technology analyst in London. In 2006 he accepted the post of Associate Director with the responsibility of setting up the new Single Technology Appraisals programme for NICE in …more ›
Patrick is Director of Market Access and External Affairs at Bristol Myers Squibb UK. In his role Patrick leads the key market access functions including Government affairs, Communications, Pricing, HTA and Field Access. He represents BMS in a number of Industry groups…more ›
Ms. Slutsky has directed the Center for Outcomes and Evidence (COE), Agency for Healthcare Research and Quality (AHRQ) of the U.S. Department of Health and Human Services since June 2003. Prior to Ms. Slutsky’s appointment as director of COE, she served as acting direc…more ›
The leading policy forum on international pricing & reimbursement
Pharma Pricing and Market Access Outlook Europe is the world’s largest gathering of pharmaceutical pricing, market access and reimbursement professionals regularly attracting a high attendance.
It is a two day strategic conference addressing the critical policy issues in developing the optimum pricing strategy for pharmaceutical products.
Sponsors
Come to Pharma Pricing and Market Access Outlook Europe and learn:
- How the policy challenges in market access will effect you
- How to produce an optimum pricing strategy for your pharma products
- How HTA practice effects the markets you are working in
- How innovative pricing and risk sharing models between industry and payers have changed
World class solution providers attend to:
- Position their products and services in front of decision makers
- Meet senior execs within the pharma Pricing and market access space
- Position themseleves as a leader in Europe
- Generate leads and new business
Who should sponsor:
- CRO’s
- Niche CRO’s
- IT/Software/Data Providers
- Consultants
- Communications agencies
- Law firms and legal advisors
Who should attend:
- Head of Pricing & Reimbursement
- Head of Market Access
- Head of Health Ecomonics
- Head of Outcomes Research
- Head of Heath Policy
- Head of Health Outcomes
- Head of Pharmacoeconomics
- Head of HTA
- Head of Public Policy
